OCUGEN, INC.
Last · NASDAQ$1.36+0.01 (+0.74%)stale · yahoo · 103h ago
Market cap$461.19M339.1M sh
P/E · TTM-5.2fwd -5.1 · eps -0.26 · loss
Beta2.21vs S&P 500
Div yield—annual · TTM
52w range
$1.01$2.725
Volume3.6Msession
Loading chart…
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.05
Est. revenue
780,000
Earnings transcripts
Press & signals
- GlobeNewswire
Ocugen Provides Business Update with Second Quarter 2026 Financial Results
- GlobeNewswire
Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa